Follicle stimulating hormone and anti-müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: A cohort study

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Weghofer, Andrea ^a,b   Kim, Ann ^b   Barad, David H ^b,c   Gleicher, Norbert ^b,d  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b The Center for Human Reproduction and Foundation for Reproductive Medicine   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG RESPONSE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN EMBRYO; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY FOLLICLE MATURATION; PREDICTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; BIOLOGICAL MODEL; BLOOD; CYTOLOGY; OOCYTE; OVULATION INDUCTION; PREGNANCY RATE;

ADULT; ANTI-MULLERIAN HORMONE; COHORT STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MODELS, BIOLOGICAL; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 84860146806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034290     Document Type: Article

References (35)

1. Deb S, Batcha M, Campbell BK, Jayaprakasan K, Clewes JS, et al. (2009) The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART. Hum Reprod 24: 2124-2132.
2. Haadsma ML, Bukman A, Groen H, Roeloffzen EM, Groenewoud ER, et al. (2007) The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod 22: 1925-1931.
3. Barad DH, Weghofer A, Gleicher N, (2007) Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 109: 1404-1410.
4. Abdalla H, Thum MY, (2004) An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 19: 893-898.
5. Almog B, Shehata F, Suissa S, Holzer H, Shalom-Paz E, et al. (2011) Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95: 2359-2363, 2363 e2351.
6. Barad DH, Weghofer A, Gleicher N, (2009) Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril 91: 1553-1555.
7. Holte J, Brodin T, Berglund L, Hadziosmanovic N, Olovsson M, et al. (2011) Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries. Fertil Steril 96: 594-599.
8. Gleicher N, Weghofer A, Barad DH, (2011) Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 9: 23.
9. Elgindy EA, El-Haieg DO, El-Sebaey A, (2008) Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril 89: 1670-1676.
10. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, et al. (2009) Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 92: 1586-1593.
11. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, et al. (2009) Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 24: 867-875.
12. Gleicher N, Weghofer A, Barad DH, (2010) Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 94: 2824-2827.
13. Weghofer A, Dietrich W, Barad DH, Gleicher N, (2011) Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod 26: 1905-1909.
14. Tremellen K, Kolo M, (2010) Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. Aust N Z J Obstet Gynaecol 50: 568-572.
15. Yates AP, Rustamov O, Roberts SA, Lim HY, Pemberton PW, et al. (2011) Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod 26: 2353-2362.
16. Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, et al. (2011) Anti-Mullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online 22 (Suppl 1): S88-93.
17. La Marca A, Papaleo E, D'Ippolito G, Grisendi V, Argento C, et al. (2011) The ovarian follicular pool and reproductive outcome in women. Gynecol Endocrinol.
18. Fortune JE, Rivera GM, Yang MY, (2004) Follicular development: the role of the follicular microenvironment in selection of the dominant follicle. Anim Reprod Sci 82-83: 109-126.
19. Gleicher N, Kim A, Weghofer A, Barad DH, Toward a Better Understanding of Functional Ovarian Reserve: AMH (AMHo) and FSH (FSHo) Hormone Ratios per Retrieved Oocyte. J Clin Endocrinol Metab (in press).
20. Freour T, Mirallie S, Bach-Ngohou K, Denis M, Barriere P, et al. (2007) Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 375: 162-164.
21. Barad D, Gleicher N, (2006) Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 21: 2845-2849.
22. Barad DH, Weghofer A, Gleicher N, (2011) Utility of age-specific serum anti-Mullerian hormone concentrations. Reprod Biomed Online 22: 284-291.
23. Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, et al. (2011) Antimullerian hormone and polycystic ovary syndrome. Fertil Steril 96: 230-235.
24. Weghofer A, Dietrich W, Ortner I, Bieglmayer C, Barad D, et al. (2011) Anti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery. Reprod Biol Endocrinol 9: 98.
25. van den Berg MH, van Dulmen-den Broeder E, Overbeek A, Twisk JW, Schats R, et al. (2010) Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod 25: 1520-1527.
26. Nelson SM, Messow MC, McConnachie A, Wallace H, Kelsey T, et al. (2011) External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients. Reprod Biomed Online 23: 204-206.
27. Buyuk E, Seifer DB, Younger J, Grazi RV, Lieman H, (2011) Random anti-Mullerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels. Fertil Steril 95: 2369-2372.
28. Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, et al. (2011) Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril 95: 410-412.
29. Onagawa T, Shibahara H, Ayustawati, Machida S, Hirano Y, et al. (2004) Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer. Gynecol Endocrinol 18: 335-340.
30. Gleicher N, Weghofer A, Barad DH, (2011) The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 9: 116.
31. Andersen CY, (1993) Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 77: 1227-1234.
32. Gleicher N, Weghofer A, Barad DH, (2010) Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrinol 8: 64.
33. Swanton A, Storey L, McVeigh E, Child T, (2011) IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol 149: 68-71.
34. Chen QJ, Sun XX, Li L, Gao XH, Wu Y, et al. (2007) Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand 86: 849-854.
35. Pellicer A, Valbuena D, Cano F, Remohi J, Simon C, (1996) Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 65: 1190-1195.